Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rickettsial perimyocarditis--a follow-up study.

B Maisch

    Heart and Vessels
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Autoantibodies against cardiac myolemma (AMLA) were found in a Q-fever perimyocarditis patient, suggesting a potential secondary immunopathogenesis for chronic Q-fever heart conditions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [2019 ESC guidelines: consensus in Europe for 25 years].

    Herz·2019
    Same author

    [The 4 R of the ESC guidelines 2018: relevance, redundancy, reality, and relativization].

    Herz·2018
    Same author

    [Management of pericarditis and pericardial effusion, constrictive and effusive-constrictive pericarditis].

    Herz·2018
    Same author

    Heart failure 2.0 or 0.1?

    Herz·2018
    Same author

    Treatment options in myocarditis and inflammatory cardiomyopathy : Focus on i. v. immunoglobulins.

    Herz·2018
    Same author

    [ESC guidelines 2017 : What is new and what is of particular importance?]

    Herz·2017
    Same journal

    Microvascular angina beyond risk markers: the need for endotype-specific validation.

    Heart and vessels·2026
    Same journal

    Impact of 1-month dual antiplatelet therapy after treatment with drug-coated balloon for femoropopliteal artery disease.

    Heart and vessels·2026
    Same journal

    Combined assessment of left ventricular and atrial function for transthyretin amyloid cardiomyopathy.

    Heart and vessels·2026
    Same journal

    Exercise-based cardiac rehabilitation after aortic dissection: a systematic review of exercise prescription and blood pressure-guided management.

    Heart and vessels·2026
    Same journal

    Differential prognostic impact of interleukin-6 in acute heart failure with reduced versus preserved ejection fraction.

    Heart and vessels·2026
    Same journal

    Long-term diabetic nephropathy-related dialysis and mortality after acute myocardial infarction: a marker of advanced cardiovascular disease?

    Heart and vessels·2026
    See all related articles

    Area of Science:

    • Immunology
    • Cardiology
    • Infectious Diseases

    Background:

    • Q-fever is a zoonotic infection that can cause perimyocarditis.
    • Autoimmune responses may contribute to cardiac damage in infectious diseases.

    Observation:

    • A patient with acute Q-fever perimyocarditis developed antimyolemmal antibodies (AMLA).
    • These AMLA were muscle-specific, cytolytic in the presence of complement, and absorbed by Coxiella burnetii.
    • Lymphocytotoxicity against cardiocytes was minimal in the patient and absent in controls.

    Findings:

    • AMLA were detected in the Q-fever perimyocarditis patient at titers up to 1:320, but not in Q-fever patients without cardiac involvement or healthy controls.
    • The patient's serum demonstrated complement-dependent cytolysis of rat cardiocytes mediated by AMLA.

    Related Experiment Videos

  • Both AMLA and cytolytic activity were specifically neutralized by Coxiella burnetii antigens.

    • Implications:

    • Cross-reacting, complement-fixing, cytolytic autoantibodies against cardiac myolemma are implicated in Q-fever perimyocarditis.
    • This suggests a secondary immunopathogenesis, where autoimmune reactions contribute to or result from cardiac damage in chronic Q-fever.
    • Understanding this autoimmune mechanism could inform future therapeutic strategies for Q-fever-related cardiac complications.